ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentAllschwilOncoGenomX AG
OncoGenomX AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

OncoGenomX AG provides PredictionStar, a therapy decision-support tool for breast cancer that analyzes tumor-specific genomic, biological, pathological and clinical data to inform treatment composition. The point-of-care platform applies patented algorithms and machine-learning–assisted drug–tumor matching, delivers analysis reports within the hospital IT environment without additional invasive procedures, and is designed for routine clinical use.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentMedical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

OncoGenomX AG

✓ Offered4
Therapy decision support (Prediction Star)
Point-of-care technology platform to support therapy decisions in breast cancer; analyses tumour-specific genomic, biological, pathological and patient-specific clinical information and delivers analysis reports.
Analysis of tumour and patient data
Analysis of tumour-specific genomic, biological, pathological and patient-specific clinical information for classifying cancer and supporting evidence-based therapy decisions.
Intelligence-augmented Drug-Tumor-Matching
Intelligence-augmented assignment of drugs to tumours based on algorithm analyses and real-world outcome data to select suitable therapy combinations.
Treatment report and clinical decision support
Real-time delivery of analysis reports and easily understandable therapy recommendations to support the selection of evidence-based treatment regimens.
Trust & reputation

ranQ Trust Score of OncoGenomX AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

OncoGenomX AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
OncoGenomX AG scores 74.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.75.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
OncoGenomX AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
OncoGenomX AG scores 31.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.31.44%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

OncoGenomX AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once OncoGenomX AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

OncoGenomX AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank OncoGenomX AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of OncoGenomX AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Kreuzstrasse 4
4123 Allschwil

At a glance

Legal form
Corporation
UID
CHE-268.986.161
Founded
2019 · 7 years
Last commercial register change
October 22, 2024
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    CA
    Crystallise! AG
    Allschwil
    NB
    Nanolynx Biologics AG
    Allschwil
    AP
    Actelion Pharmaceuticals Ltd
    Allschwil
    GG
    Gubra GmbH
    Allschwil
    IT
    Immuna Therapeutics AG
    Allschwil
    SB
    Swiss Biome Institute GmbH
    Allschwil
    IA
    InCephalo AG
    Allschwil
    H(
    HEMEX (Switzerland) AG
    Liestal